Collegium Pharmaceutical (COLL) Other Working Capital Changes (2016 - 2025)
Collegium Pharmaceutical has reported Other Working Capital Changes over the past 10 years, most recently at $8.2 million for Q4 2025.
- Quarterly results put Other Working Capital Changes at $8.2 million for Q4 2025, up 167.52% from a year ago — trailing twelve months through Dec 2025 was $8.0 million (changed N/A YoY), and the annual figure for FY2025 was $8.0 million, changed.
- Other Working Capital Changes for Q4 2025 was $8.2 million at Collegium Pharmaceutical, up from -$21.3 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for COLL hit a ceiling of $11.5 million in Q2 2024 and a floor of -$21.3 million in Q3 2025.
- Median Other Working Capital Changes over the past 5 years was $335000.0 (2022), compared with a mean of $683000.0.
- Biggest five-year swings in Other Working Capital Changes: tumbled 28961.9% in 2024 and later skyrocketed 5703.39% in 2025.
- Collegium Pharmaceutical's Other Working Capital Changes stood at $2.3 million in 2021, then skyrocketed by 141.97% to $5.6 million in 2022, then tumbled by 99.25% to $42000.0 in 2023, then tumbled by 28961.9% to -$12.1 million in 2024, then surged by 167.52% to $8.2 million in 2025.
- The last three reported values for Other Working Capital Changes were $8.2 million (Q4 2025), -$21.3 million (Q3 2025), and $10.8 million (Q2 2025) per Business Quant data.